The neurosurgeons within our Neuro-Oncology Division at Penn Medicine are consistently considered some of the top surgeons in the country. From the extremely high volume of patients, the ground-breaking techniques being established, and the extraordinary research done by our scientists; Penn Neurosurgery's Neuro-Oncology Division simply stands above the rest.
Penn Medicine’s multidisciplinary approach to the diagnosis and treatment of brain tumors provides better outcomes through advanced treatment, surgical techniques, post-operative care and clinical trials. This comprehensive approach is what allows us to be the leader of brain tumor surgery, performing the highest number of cases in Pennsylvania.
In a recent news feature, local Philadelphia news anchor Pat Ciarrocchi came to Penn Medicine to get her hearing checked out but after undergoing an MRI, a small mass was discovered in her brain. From here, she was referred to Dr. O'Rourke thinking that there's a chance that she had a brain tumor.
You can click here to read the full first person account from Pat on her experience with Penn Medicine's Neuro-Oncology Division within the Department of Neurosurgery.
A background of the Division Head of Brain Tumor at Penn Medicine, Nduka M. Amankulor, MD.
Penn Medicine's Neurosurgery Department is divided into 4 divisions. Here are the clinical faculty for Tumors.
This is an advanced surgical treatment to remove brain tumors that allows for intraoperative speech and motor mapping during the procedure.
When brain tumors are located along the base of the brain, one technique routinely used for treatment is an Endoscopic Endonasal procedure which goes through the nose.
Glioblastoma is the most common form of malignant brain cancer, representing just over 15 percent of all primary brain tumors, according to the American Brain Tumor Association.
Intraoperative MRI is a useful technique for guiding neurosurgeons when removing brain tumors and treating epilepsy.
Stereotactic radiosurgery uses a large dose of radiation to destroy tumor tissue.
TumorGlow®, a type of intraoperative molecular imaging, relies on an injectable dye that has been specially engineered to accumulate in cancerous tissues, much more so than normal tissues.